Triomune Tablets IP

Manufacturer
Cipla Ltd
Packaging
Tablet
Composition
LAMIVUDINE IP: 150MG NEVIRAPINE IP: 200MG STAVUDINE IP: 30MG
Availability
OTC
SKU
PROD-00997

Product Description

Triomune Tablets IP are a combination antiretroviral medicine containing Lamivudine, Stavudine, and Nevirapine. They are used in combination antiretroviral therapy for the treatment of Human Immunodeficiency Virus infection.

🔹 Key Uses
Triomune Tablets may be used for:

Treatment of Human Immunodeficiency Virus infection
Reduction of Human Immunodeficiency Virus viral load
Supporting immune system function
Helping slow the progression of Human Immunodeficiency Virus infection
Combination antiretroviral therapy

🔹 Composition
Active ingredients: Lamivudine + Stavudine + Nevirapine
Medicine class: Combination antiretroviral medicine
Dosage form: Tablet

🔹 How It Works
The three medicines work together to prevent Human Immunodeficiency Virus from multiplying:

Lamivudine and Stavudine inhibit the viral reverse transcriptase enzyme and interfere with viral genetic material production.
Nevirapine also inhibits reverse transcriptase through a different mechanism.

Together, they help suppress viral replication and reduce the amount of virus in the blood.

🔹 Key Benefits

Combines three antiretroviral medicines in one tablet
Helps reduce Human Immunodeficiency Virus viral load
Supports immune system function
Helps suppress viral replication
Convenient combination treatment

🔹 Dosage and Administration
The dose and treatment duration should be determined by a qualified healthcare professional.

Take exactly as prescribed.
Take the medicine consistently at the prescribed times.
Do not miss doses or stop treatment without medical advice.
Regular blood tests may be required to monitor treatment safety and effectiveness.

🔹 Possible Side Effects
Common side effects may include:

Nausea
Headache
Diarrhea
Tiredness
Abdominal discomfort
Rash

Serious side effects can include severe skin reactions, liver problems, inflammation of the pancreas, peripheral neuropathy, and changes in body fat distribution.

🔹 Precautions and Warnings

Nevirapine can cause serious liver and skin reactions, particularly during the early stages of treatment.
Stavudine can cause peripheral neuropathy and lactic acidosis, which may require immediate medical attention.
Inform your doctor about liver disease, kidney problems, or previous reactions to antiretroviral medicines.
Tell your doctor about all medicines and supplements you are taking.
Do not stop treatment without medical advice because this may increase the risk of treatment failure and drug resistance.
Seek urgent medical attention for severe rash, blistering, fever, yellowing of the skin or eyes, severe abdominal pain, unusual weakness, or numbness and tingling in the hands or feet.

Additional Information

  • Category: category change
  • Manufacturer: Cipla Ltd
  • Packaging: Tablet
  • Composition: LAMIVUDINE IP: 150MG NEVIRAPINE IP: 200MG STAVUDINE IP: 30MG
  • Storage: Store in a cool, dry place away from direct sunlight
  • Shelf Life: As per manufacturer's guidelines
  • Prescription Status: Over-the-Counter (OTC)

How to Use

Important: Always follow your healthcare provider's instructions when using this medication.

  • Take this medicine as directed by your physician
  • Do not exceed the recommended dosage
  • Complete the full course of treatment even if symptoms improve
  • Store the medication properly as per storage instructions
  • Keep out of reach of children
  • Check expiry date before use

Note: This is general guidance. For specific instructions, please consult your healthcare provider or refer to the package insert.